B7-H4 is a member of the B7 family of immunoregulatory ligands that acts as a potent inhibitory checkpoint within the tumour microenvironment. Unlike PD-L1, its receptor remains unidentified, yet its ...
RAINFOL-03 (ENGOT-EN-31/GOG-3128): A global, phase 3, open-label, randomized study of rinatabart sesutecan (Rina-S) vs investigator’s choice of chemotherapy in ...
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted ...
4 Stocks With Huge Cash Holdings at Silicon Valley Bank BeOne Medicines (NASDAQ:ONC) used an investor event at ASCO to outline what executives described as a new phase of growth beyond hematology, ...
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or antigen-binding fragments targeting V-set ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results